Pharmionics in dermatology: A review of topical medication adherence

American Journal of Clinical Dermatology

Volumn 7, Issue 4, 2006, Pages 231-236

  Lee, Ivy A ^a   Maibach, Howard I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; BENZOYL PEROXIDE; CALCIPOTRIOL; CORTICOSTEROID; EMOLLIENT AGENT; ISOTRETINOIN; NONSTEROID ANTIINFLAMMATORY AGENT; RETINOID; SUNSCREEN; TOPICAL AGENT;

ACNE; ATOPIC DERMATITIS; CLINICAL TRIAL; DERMATOLOGY; HUMAN; MELANOMA; PATIENT COMPLIANCE; PHOTOTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; PSORIASIS; REVIEW; SECONDARY PREVENTION; SKIN CANCER; SKIN DISEASE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; DERMATOLOGIC AGENTS; HUMANS; PATIENT COMPLIANCE; SKIN DISEASES;

EID: 33747192600     PISSN: 11750561     EISSN: 11750561     Source Type: Journal    
DOI: 10.2165/00128071-200607040-00004     Document Type: Review

References (32)

1. Gerbino PP. Patient compliance. Ann Pharmacother 1993; 27: S3-16
2. Vrijens B, Urquhart J. Patient adherence to prescribed antimicrobial drug dosing regimens. J Antimicrob Chemother 2005; 55 (5): 616-27
3. McKenney JM, Munroe WP, Wright JT. Impact of an electronic medication compliance aid in long-term blood pressure control. J Clin Pharmacol 1992; 32: 277-83
4. Cheng CWR, Woo KS, Chan JCN, et al. Assessing adherence to statin therapy using patient report, pill count, and an electronic monitoring advice. Am J Health Syst Pharm 2005; 62: 411-5
5. Kogut SJ, Andrade SE, Willey C, et al. Nonadherence as a predictor of antidiabetic drug therapy intensification (augmentation). Pharmacoepidemiol Drug Saf 2004; 13: 591-8
6. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133: 21-30
7. Cramer J, Vachon L, Desforges C, et al. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia 1995; 36 (11): 1111-7
8. Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? JAMA 1989; 261 (22): 3273-7
9. Cramer JA. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 1995; 49 (3): 321-6
10. Balkrishnan R, Carroll CL, Camacho FT, et al. Electronic monitoring of medication adherence in skin disease: results of a pilot study. J Am Acad Dermatol 2003; 49 (4): 651-4
11. Carroll CL, Feldman SR, Camacho FT, et al. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol 2004; 51 (2): 212-6
12. Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther 1998; 20 (4): 764-71
13. Cramer JA. Relationship between medication compliance and medical outcomes. Am J Health Syst Pharm 1995; 52 (S3): S27-9
14. Urquhart J. Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens. Pharmacoeconomics 1999; 15 (3): 217-28
15. Sleath B, Roter D, Chewning B, et al. Asking questions about medication: analysis of physician-patient interactions and physician perceptions. Med Care 1999; 37 (11): 1169-73
16. Witkowski JA. Compliance: the dermatologic patient. Int J Dermatol 1998; 27 (9): 608-11
17. Zaghoul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol 2004; 140: 408-14
18. Richards HL, Fortune DG, O'Sullivan TM, et al. Patients with psoriasis and their compliance with medication. J Am Acad Dermatol 1999; 41 (4): 581-3
19. Carroll CL, Feldman SR, Camacho FT, et al. Better medication adherence results in greater improvement in severity of psoriasis. Br J Dermatol 2004; 151: 895-7
20. Osborne JE, Hutchinson PE. The importance of accurate dosage of topical agents: a method of estimating involved area and application to calcipotriol treatment failures. J Eur Acad Dermatol Venereol 2002; 16: 367-73
21. Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000; 142: 931-6
22. Cork MJ, Britton J, Butler L, et al. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 2003; 149: 582-9
23. Zaghoul SS, Cunliffe WJ, Goodfield MJD. Objective assessment of compliance with treatments in acne. Br J Dermatol 2005; 152: 1015-21
24. Boggild AK, From L. Barriers to sun safety in a Canadian outpatient population. J Cutan Med Surg 2003; 7 (4): 292-9
25. Geller AC, Shamban J, O'Riordan DL, et al. Raising sun protection and early detection awareness among Florida high schoolers. Pediatr Dermatol 2005; 22 (2): 112-8
26. Neale R, Williams G, Green A. Application patterns among participants randomized to daily sunscreen use in a skin cancer prevention trial. Arch Dermatol 2002; 138: 1319-25
27. Seuker DC, Newstead CG, Cunliffe WJ. The compliance of renal transplant recipients with advice about sun protection measures. Br J Dermatol 1998; 138: 301-3
28. Robinson JK. Behavior modification obtained by sun protection education coupled with removal of a skin cancer. Arch Dermatol 1990; 126 (4): 477-81
29. Freiman A, Yu J, Loutfi A, et al. Impact of melanoma diagnosis on sun-awareness and protection: efficacy of education campaigns in a high-risk population. J Cut Med Surg 2004 Sep/Oct; 8 (5): 303-9
30. Koehler AM, Maibach HI. Electronic monitoring in medication adherence measurement: implications for dermatology. Am J Clin Dermatol 2001; 2 (1): 7-12
31. Epstein E. Common skin disorders: a physician's illustrated manual with patient instruction sheets. Oradell (NJ): Medical Economics Books, 1998
32. Chren MM, Lasek RJ, Flocke SA, et al. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997; 133: 1433-40